Literature DB >> 18980502

Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis.

Jennifer L Reed1, Yambasu A Brewah, Tracy Delaney, Timothy Welliver, Timothy Burwell, Ebony Benjamin, Ellen Kuta, Alexander Kozhich, LuAnn McKinney, JoAnn Suzich, Peter A Kiener, Luis Avendano, Luis Velozo, Alison Humbles, Robert C Welliver, Anthony J Coyle.   

Abstract

Although respiratory syncytial virus (RSV) infection is the most important cause of bronchiolitis in infants, the pathogenesis of RSV disease is poorly described. We studied histopathologic changes in a panel of lung tissue specimens obtained from infants with fatal cases of primary RSV infection. In these tissues, airway occlusion with accumulations of infected, apoptotic cellular debris and serum protein was consistently observed. Similar observations were found after RSV infection in New Zealand black (NZB) mice, which have constitutive deficiencies in macrophage function, but not in BALB/c mice. A deficiency in the number of alveolar macrophages in NZB mice appears to be central to enhanced disease, because depletion of alveolar macrophages in BALB/c mice before RSV exposure resulted in airway occlusion. In mice with insufficient numbers of macrophages, RSV infection yielded an increased viral load and enhanced expression of type I interferon-associated genes at the height of disease. Together, our data suggest that innate, rather than adaptive, immune responses are critical determinants of the severity of RSV bronchiolitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980502     DOI: 10.1086/593173

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice.

Authors:  Michelle D Tate; Danielle L Pickett; Nico van Rooijen; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 2.  Therapeutic targeting of respiratory syncytial virus G-protein.

Authors:  Lawrence M Kauvar; Jennifer L Harcourt; Lia M Haynes; Ralph A Tripp
Journal:  Immunotherapy       Date:  2010-09       Impact factor: 4.196

3.  Immune response to intrapharyngeal LPS in neonatal and juvenile mice.

Authors:  Sharon A McGrath-Morrow; Seakwoo Lee; Kevin Gibbs; Armando Lopez; Joseph M Collaco; Enid Neptune; Mark J Soloski; Alan Scott; Franco D'Alessio
Journal:  Am J Respir Cell Mol Biol       Date:  2015-03       Impact factor: 6.914

4.  Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.

Authors:  Annemieke Schuurhof; Louis Bont; Jeroen L A Pennings; Hennie M Hodemaekers; Piet W Wester; Annemarie Buisman; Lia C G H de Rond; Myra N Widjojoatmodjo; Willem Luytjes; Jan L L Kimpen; Riny Janssen
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

Review 5.  Challenges and future in vaccines, drug development, and immunomodulatory therapy.

Authors:  Heather M Kling; Gerard J Nau; Ted M Ross; Thomas G Evans; Krishnendu Chakraborty; Kerry M Empey; JoAnne L Flynn
Journal:  Ann Am Thorac Soc       Date:  2014-08

Review 6.  Animal models of human respiratory syncytial virus disease.

Authors:  Reinout A Bem; Joseph B Domachowske; Helene F Rosenberg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

7.  Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants.

Authors:  James F Papin; Roman F Wolf; Stanley D Kosanke; Justin D Jenkins; Sara N Moore; Michael P Anderson; Robert C Welliver
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-02-15       Impact factor: 5.464

8.  Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection.

Authors:  Kreso Bendelja; Valerija Vojvoda; Neda Aberle; Jasna Cepin-Bogovic; Alenka Gagro; Gordana Mlinaric-Galinovic; Sabina Rabatic
Journal:  Respir Res       Date:  2010-10-14

9.  IgE cross-linking critically impairs human monocyte function by blocking phagocytosis.

Authors:  David M Pyle; Victoria S Yang; Rebecca S Gruchalla; J David Farrar; Michelle A Gill
Journal:  J Allergy Clin Immunol       Date:  2013-02       Impact factor: 10.793

10.  Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection.

Authors:  Deepthi Kolli; Meera R Gupta; Elena Sbrana; Thangam S Velayutham; Hong Chao; Antonella Casola; Roberto P Garofalo
Journal:  Am J Respir Cell Mol Biol       Date:  2014-10       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.